Massivemarkets

RVTY

Revvity, Inc.

NYSE · usd

$158.77+0.00 (+0.00%)
As of 7:30:04 PM EDT on Oct 23, 2026 · 15-minute delayed

Revvity, Inc. (RVTY) trades at $158.77 (+0.00%) as of 7:30:04 PM EDT on Oct 23, 2026, +5.37% over the past month. Market cap is $17.56B, with 2.4 days to cover in short interest.

Stock performance

How Revvity, Inc. (RVTY) stock has performed from one day to one year, with its 52-week range.

+2.88%
+$4.44 over 1D
$154.63$155.94$157.26$158.579:30 AM11:10 AM12:50 PM2:25 PM8:00 PM$158.77
1D
+0.90%
1W
+4.02%
1M
+5.37%
YTD
+64.10%
1Y
+63.41%
52-wk range
$81.22 – $166.25

Key statistics

Today's trading snapshot for RVTY: day range, open, previous close, volume and market cap.

Day range
$152.73 – $159.05
Open
$156.35
Prev close
$158.77
Volume
1.11M
Market cap
$17.56B
Shares out
111.59M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Revvity, Inc.: P/E, P/S, P/B, ROE and more.

P/E
73.92
P/S
6.03
P/B
2.43
P/FCF
31.46
ROE
3.3%
ROA
2.0%
Debt/Equity
0.44
Div yield
0.18%

As of Oct 22, 2026

8-K filings

Material corporate events Revvity, Inc. has disclosed to the SEC on Form 8-K.

  • Deal agreementsAug 4, 2026

    Exhibit 99.2 to the Current Report on Form 8-K sets forth the unaudited pro forma condensed consolidated financial statements to present the pro forma financial position and results of operations of the Company and its Subsidiaries based upon historical financial information after giving effect to the probable sale of substantially all of the assets related to the Company's Immunodiagnostics business in China ("China IDX") pursuant to a definitive agreement signed on July 31, 2026. The agreement provides for the sale of China IDX for up to $200 million, subject to adjustments and satisfaction of conditions.

  • Governance documentsMay 1, 2026

    the shareholders voted on and approved a proposal to amend the Company's Amended and Restated By-laws (prior to such amendment and restatement, the "Prior By-laws") to allow shareholders owning 25% of the Company's stock to call a special meeting of shareholders (as amended and restated, the "Amended and Restated By-laws") effective as of April 28, 2026.

  • Investor communicationsJan 13, 2026

    On January 13, 2026, Dr. Prahlad Singh, President and Chief Executive Officer of the Company, is scheduled to make a presentation to the 44th Annual J. P. Morgan Healthcare Conference. A copy of the presentation materials is furnished as Exhibit 99.2 to this Current Report on Form 8-K.

  • Executive leadershipOct 24, 2025

    On October 23, 2025, the Board of Directors (the "Board") of Revvity, Inc. (the "Company") appointed Anita Gonzales, the Company's Vice President and Controller, to serve as its Vice President and Chief Accounting Officer, effective immediately.

  • Governance documentsApr 25, 2025

    In connection with the Majority Voting Standard, the board of directors of the Company approved an amendment and restatement of the Company's Amended and Restated By-laws... to, among other updates, implement the Majority Voting Standard (as amended and restated, the "Amended and Restated By-laws") effective as of April 24, 2025.

Dividend history and stock splits

Revvity, Inc.'s recent dividend payments and stock splits.

Dividends

  • $0.07ex-div Oct 23, 2026
  • $0.07ex-div Jul 17, 2026
  • $0.07ex-div Apr 17, 2026
  • $0.07ex-div Jan 16, 2026

Splits

No recent splits.

RVTY short interest

How heavily RVTY is shorted: shares short, days to cover and average daily volume.

Days to cover
2.4
Short interest
6.3M
Avg volume
2.61M

As of · reported to FINRA twice monthly.

RVTY news

The latest news and headlines about Revvity, Inc. (RVTY).

Frequently asked questions

What is the Revvity, Inc. (RVTY) stock price today?

Revvity, Inc. (RVTY) is trading at $158.77 (+0.00% on the day) as of 7:30:04 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Revvity, Inc.?

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and…

What is the short interest in RVTY?

As of Sep 30, 2026, RVTY has 6.3M shares short and 2.4 days to cover.

Does Revvity, Inc. (RVTY) pay a dividend?

Yes. Revvity, Inc. (RVTY)'s most recent dividend was $0.07 per share, with an ex-dividend date of Oct 23, 2026. Full RVTY dividend history is available from the Massive API.

What exchange is RVTY listed on?

Revvity, Inc. (RVTY) trades on NYSE in USD, in the LABORATORY ANALYTICAL INSTRUMENTS industry.

Build with AI

Build an analysis of RVTY with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a RVTY analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Want the most up-to-date, real-time data? Connect to the Massive API and MCP server — the source behind every number on this page — covering stocks, options, indices, currencies and futures. Docs: https://massive.com/docs/rest. Get a free API key.

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.